Prostate Cancer Clinical Trials in Seattle

Showing 181-183 of 183 trials

Study of Aranesp to Treat Anemia in Prostate Cancer Patients.

NCT00245895

The purpose of this study is to see if darbepoetin alfa is an effective treatment for anemia in prostate cancer patients and, if so, what dose is most effective. Sometimes prostate cancer patients have low red blood cell counts (low hemoglobin) from various treatments they are receiving, such as chemotherapy. The red blood cells deliver oxygen to the tissue. This then helps give the patient more energy.

Prostate CancerAnemia

University of Washington20 participantsStarted Apr 2003

Portland, Oregon, United States • Seattle, Washington, United States

TERMINATEDPhase 3< 1 mile

DN-101 in Combination With Docetaxel in Androgen-Independent Prostate Cancer (AIPC) (AIPC Study of Calcitriol Enhancing Taxotere [ASCENT-2])

NCT00273338

The primary objective of this study is: * To evaluate the effect of DN-101 in combination with docetaxel (ASCENT regimen) on survival in metastatic androgen-independent prostate cancer The secondary objectives of this study are: * To determine the effect of the ASCENT regimen on the rate of thromboembolic events (blood clots) * To determine the effect of the ASCENT regimen on prevention of skeletal-related events (fractures) * A Separate sub-study will be conducted at selected study sites in North America to determine the population PK of DN-101.

Prostate Cancer

Novacea1,200 participantsStarted Jan 2006

Birmingham, Alabama, United States • Muscle Shoals, Alabama, United States • Anchorage, Alaska, United States +219 more locations

Study of Aranesp to Treat Anemia in Prostate Cancer Patients.

DN-101 in Combination With Docetaxel in Androgen-Independent Prostate Cancer (AIPC) (AIPC Study of Calcitriol Enhancing Taxotere [ASCENT-2])

Prostate Cancer Trials in Other Cities

I-125 Versus Pd-103 for Medium Risk Prostate Cancer

Other Conditions in Seattle